Ircon International Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 5, 2025, 10:40 pm

Quick Insight

Ircon International Ltd's current market price of 161 reflects a Price-to-Earnings ratio of 22.7, indicating potential overvaluation compared to its Return on Equity of 11.9% and Return on Capital Employed of 12.1%. The company's Operating Profit Margin stands at 11%, with a Net Profit of 728Cr and Reserves at 6,138Cr. However, Ircon's high Price-to-Book Value of 3.51x and Interest Coverage Ratio of 9.86x suggest a strong investor interest despite a substantial debt burden of ₹4,299Cr. With a Cash Conversion Cycle of just 1 day, Ircon appears efficient in managing its working capital. Investors should closely monitor the company's ability to leverage its reserves effectively to drive sustainable growth amidst its high borrowing levels.

Competitors of Ircon International Ltd

All Competitor Stocks of Ircon International Ltd

Quarterly Result

Last Updated: August 20, 2025, 8:50 am

Below is a detailed analysis of the quarterly data for Ircon International Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,786.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,412.00 Cr. (Mar 2025) to 1,786.00 Cr., marking a decrease of 1,626.00 Cr..
• For Expenses, as of Jun 2025, the value is 1,586.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3,158.00 Cr. (Mar 2025) to 1,586.00 Cr., marking a decrease of 1,572.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 200.00 Cr.. The value appears to be declining and may need further review. It has decreased from 254.00 Cr. (Mar 2025) to 200.00 Cr., marking a decrease of 54.00 Cr..
• For OPM %, as of Jun 2025, the value is 11.00%. The value appears strong and on an upward trend. It has increased from 7.00% (Mar 2025) to 11.00%, marking an increase of 4.00%.
• For Other Income, as of Jun 2025, the value is 124.00 Cr.. The value appears strong and on an upward trend. It has increased from 103.00 Cr. (Mar 2025) to 124.00 Cr., marking an increase of 21.00 Cr..
• For Interest, as of Jun 2025, the value is 75.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 62.00 Cr. (Mar 2025) to 75.00 Cr., marking an increase of 13.00 Cr..
• For Depreciation, as of Jun 2025, the value is 37.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 32.00 Cr. (Mar 2025) to 37.00 Cr., marking an increase of 5.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 212.00 Cr.. The value appears to be declining and may need further review. It has decreased from 263.00 Cr. (Mar 2025) to 212.00 Cr., marking a decrease of 51.00 Cr..
• For Tax %, as of Jun 2025, the value is 22.00%. The value appears to be increasing, which may not be favorable. It has increased from 19.00% (Mar 2025) to 22.00%, marking an increase of 3.00%.
• For Net Profit, as of Jun 2025, the value is 164.00 Cr.. The value appears to be declining and may need further review. It has decreased from 212.00 Cr. (Mar 2025) to 164.00 Cr., marking a decrease of 48.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.75. The value appears to be declining and may need further review. It has decreased from 2.24 (Mar 2025) to 1.75, marking a decrease of 0.49.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 5:09 pm

Growth

Last Updated: September 5, 2025, 7:50 am

Balance Sheet

Last Updated: June 16, 2025, 11:55 am

Below is a detailed analysis of the balance sheet data for Ircon International Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 188.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 188.00 Cr..
• For Reserves, as of Mar 2025, the value is 6,138.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,683.00 Cr. (Mar 2024) to 6,138.00 Cr., marking an increase of 455.00 Cr..
• For Borrowings, as of Mar 2025, the value is 4,299.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 2,570.00 Cr. (Mar 2024) to 4,299.00 Cr., marking an increase of 1,729.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 8,896.00 Cr.. The value appears to be improving (decreasing). It has decreased from 9,004.00 Cr. (Mar 2024) to 8,896.00 Cr., marking a decrease of 108.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 19,521.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17,445.00 Cr. (Mar 2024) to 19,521.00 Cr., marking an increase of 2,076.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 2,453.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,736.00 Cr. (Mar 2024) to 2,453.00 Cr., marking an increase of 717.00 Cr..
• For CWIP, as of Mar 2025, the value is 976.00 Cr.. The value appears strong and on an upward trend. It has increased from 549.00 Cr. (Mar 2024) to 976.00 Cr., marking an increase of 427.00 Cr..
• For Investments, as of Mar 2025, the value is 1,296.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,553.00 Cr. (Mar 2024) to 1,296.00 Cr., marking a decrease of 257.00 Cr..
• For Other Assets, as of Mar 2025, the value is 14,796.00 Cr.. The value appears strong and on an upward trend. It has increased from 13,607.00 Cr. (Mar 2024) to 14,796.00 Cr., marking an increase of 1,189.00 Cr..
• For Total Assets, as of Mar 2025, the value is 19,521.00 Cr.. The value appears strong and on an upward trend. It has increased from 17,445.00 Cr. (Mar 2024) to 19,521.00 Cr., marking an increase of 2,076.00 Cr..

Notably, the Reserves (6,138.00 Cr.) exceed the Borrowings (4,299.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Ircon International Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 9.88. This value is within the healthy range. It has increased from 8.14 (Mar 23) to 9.88, marking an increase of 1.74.
• For Diluted EPS (Rs.), as of Mar 24, the value is 9.88. This value is within the healthy range. It has increased from 8.14 (Mar 23) to 9.88, marking an increase of 1.74.
• For Cash EPS (Rs.), as of Mar 24, the value is 10.46. This value is within the healthy range. It has increased from 8.94 (Mar 23) to 10.46, marking an increase of 1.52.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 62.80. It has increased from 55.55 (Mar 23) to 62.80, marking an increase of 7.25.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 62.80. It has increased from 55.55 (Mar 23) to 62.80, marking an increase of 7.25.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 131.11. It has increased from 110.24 (Mar 23) to 131.11, marking an increase of 20.87.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 15.56. This value is within the healthy range. It has increased from 11.54 (Mar 23) to 15.56, marking an increase of 4.02.
• For PBIT / Share (Rs.), as of Mar 24, the value is 14.50. This value is within the healthy range. It has increased from 10.39 (Mar 23) to 14.50, marking an increase of 4.11.
• For PBT / Share (Rs.), as of Mar 24, the value is 12.92. This value is within the healthy range. It has increased from 9.14 (Mar 23) to 12.92, marking an increase of 3.78.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 9.39. This value is within the healthy range. It has increased from 7.80 (Mar 23) to 9.39, marking an increase of 1.59.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 9.88. This value is within the healthy range. It has increased from 8.14 (Mar 23) to 9.88, marking an increase of 1.74.
• For PBDIT Margin (%), as of Mar 24, the value is 11.87. This value is within the healthy range. It has increased from 10.46 (Mar 23) to 11.87, marking an increase of 1.41.
• For PBIT Margin (%), as of Mar 24, the value is 11.05. This value is within the healthy range. It has increased from 9.42 (Mar 23) to 11.05, marking an increase of 1.63.
• For PBT Margin (%), as of Mar 24, the value is 9.85. This value is below the healthy minimum of 10. It has increased from 8.29 (Mar 23) to 9.85, marking an increase of 1.56.
• For Net Profit Margin (%), as of Mar 24, the value is 7.16. This value is within the healthy range. It has increased from 7.07 (Mar 23) to 7.16, marking an increase of 0.09.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 7.53. This value is below the healthy minimum of 8. It has increased from 7.38 (Mar 23) to 7.53, marking an increase of 0.15.
• For Return on Networth / Equity (%), as of Mar 24, the value is 15.83. This value is within the healthy range. It has increased from 14.68 (Mar 23) to 15.83, marking an increase of 1.15.
• For Return on Capital Employeed (%), as of Mar 24, the value is 13.20. This value is within the healthy range. It has increased from 11.81 (Mar 23) to 13.20, marking an increase of 1.39.
• For Return On Assets (%), as of Mar 24, the value is 5.32. This value is within the healthy range. It has increased from 4.92 (Mar 23) to 5.32, marking an increase of 0.40.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.41. This value is within the healthy range. It has increased from 0.27 (Mar 23) to 0.41, marking an increase of 0.14.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.43. This value is within the healthy range. It has increased from 0.28 (Mar 23) to 0.43, marking an increase of 0.15.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.74. It has increased from 0.69 (Mar 23) to 0.74, marking an increase of 0.05.
• For Current Ratio (X), as of Mar 24, the value is 1.68. This value is within the healthy range. It has increased from 1.54 (Mar 23) to 1.68, marking an increase of 0.14.
• For Quick Ratio (X), as of Mar 24, the value is 1.65. This value is within the healthy range. It has increased from 1.51 (Mar 23) to 1.65, marking an increase of 0.14.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.38. This value is below the healthy minimum of 4. It has increased from 1.61 (Mar 23) to 2.38, marking an increase of 0.77.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 30.35. This value is within the healthy range. It has increased from 30.11 (Mar 23) to 30.35, marking an increase of 0.24.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 27.39. This value is within the healthy range. It has increased from 26.40 (Mar 23) to 27.39, marking an increase of 0.99.
• For Earning Retention Ratio (%), as of Mar 24, the value is 69.65. This value is within the healthy range. It has decreased from 69.89 (Mar 23) to 69.65, marking a decrease of 0.24.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 72.61. This value exceeds the healthy maximum of 70. It has decreased from 73.60 (Mar 23) to 72.61, marking a decrease of 0.99.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 9.86. This value is within the healthy range. It has increased from 9.19 (Mar 23) to 9.86, marking an increase of 0.67.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 6.95. This value is within the healthy range. It has decreased from 7.21 (Mar 23) to 6.95, marking a decrease of 0.26.
• For Enterprise Value (Cr.), as of Mar 24, the value is 18,205.56. It has increased from 1,661.58 (Mar 23) to 18,205.56, marking an increase of 16,543.98.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.48. This value is within the healthy range. It has increased from 0.16 (Mar 23) to 1.48, marking an increase of 1.32.
• For EV / EBITDA (X), as of Mar 24, the value is 12.44. This value is within the healthy range. It has increased from 1.53 (Mar 23) to 12.44, marking an increase of 10.91.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.67. This value is within the healthy range. It has increased from 0.50 (Mar 23) to 1.67, marking an increase of 1.17.
• For Retention Ratios (%), as of Mar 24, the value is 69.64. This value is within the healthy range. It has decreased from 69.88 (Mar 23) to 69.64, marking a decrease of 0.24.
• For Price / BV (X), as of Mar 24, the value is 3.51. This value exceeds the healthy maximum of 3. It has increased from 1.01 (Mar 23) to 3.51, marking an increase of 2.50.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.67. This value is within the healthy range. It has increased from 0.50 (Mar 23) to 1.67, marking an increase of 1.17.
• For EarningsYield, as of Mar 24, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.14 (Mar 23) to 0.04, marking a decrease of 0.10.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness